Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 15, 2026, 6:55 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 241–264 of 365 matching trials from the live ClinicalTrials.gov search.

Filters: Condition: Obsessive Compulsive Disorder (OCD) Clear all

Conditions: Obsessive-Compulsive Disorder
Interventions: olanzapine + fluoxetine, placebo + fluoxetine; Drug
Lead sponsor: University of Florida; Other
Eligibility: 14 Years to 70 Years
Enrollment: 74 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 1992 – 2003
U.S. locations: 2
States / cities: Gainesville, Florida • Jacksonville, Florida

Conditions: Obsessive-Compulsive Disorder
Interventions: Transcranial Magnetic Stimulation; Device
Lead sponsor: Bradley Hospital; Other
Eligibility: 13 Years to 18 Years
Enrollment: 7 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2023
U.S. locations: 1
States / cities: Riverside, Rhode Island

Conditions: Hoarding Disorder
Interventions: Methylphenidate ER; Drug
Lead sponsor: New York State Psychiatric Institute; Other
Eligibility: 18 Years to 50 Years
Enrollment: 4 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2010 – 2011
U.S. locations: 2
States / cities: Hartford, Connecticut • New York, New York

Conditions: Obsessive-Compulsive Disorder
Interventions: Not listed
Lead sponsor: Massachusetts General Hospital; Other
Eligibility: 21 Years to 64 Years
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2022
U.S. locations: 1
States / cities: Charlestown, Massachusetts

Conditions: Obsessive-Compulsive Disorder
Interventions: Individual Child CBT, Positive Family Interaction Therapy; Behavioral
Lead sponsor: University of California, Los Angeles; Other
Eligibility: 8 Years to 17 Years
Enrollment: 62 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2008 – 2016
U.S. locations: 1
States / cities: Los Angeles, California

Conditions: Obsessive-Compulsive Disorder in Children, Anxiety Disorder of Childhood, Social Anxiety Disorder of Childhood, Obsessive-Compulsive Disorder in Adolescence, Generalized Anxiety Disorder, Separation Anxiety, Panic Disorder, Panic Disorder With Agoraphobia, Panic Attacks
Interventions: Family Based, Internet-Based Cognitive Behavioral Therapy, Bibliotherapy, low therapist contact SPACE, Relaxation and Mentorship; Behavioral · Other
Lead sponsor: Baylor College of Medicine; Other
Eligibility: 7 Years to 13 Years
Enrollment: 100 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2026
U.S. locations: 1
States / cities: Houston, Texas

Conditions: Obsessive-Compulsive Disorder
Interventions: Ketamine, Midazolam; Drug
Lead sponsor: Stanford University; Other
Eligibility: 18 Years to 65 Years
Enrollment: 120 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2016 – 2021
U.S. locations: 1
States / cities: Stanford, California

Conditions: Patient Diagnosed With OCD and Resistant to SSRI Treatment, Failed SSRI Over 12 Weeks at Appropriate Doses
Interventions: AFQ056, Placebo; Drug
Lead sponsor: Novartis Pharmaceuticals; Industry
Eligibility: 18 Years to 65 Years
Enrollment: 50 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2013 – 2014
U.S. locations: 3
States / cities: San Diego, California • Watertown, Massachusetts • Brooklyn, New York

Conditions: Obsessive-compulsive Disorders and Symptoms, Obsessive-Compulsive Disorder
Interventions: BIXINK OC Free; Device
Lead sponsor: BIXINK Therapeutics Co., Ltd.; Industry
Eligibility: 18 Years and older
Enrollment: 30 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2023
U.S. locations: 1
States / cities: New York, New York

Conditions: Hoarding Disorder
Interventions: Imaginal Exposure Writing, Neutral Writing; Behavioral · Other
Lead sponsor: Stanford University; Other
Eligibility: 18 Years and older
Enrollment: 32 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2021
U.S. locations: 1
States / cities: Palo Alto, California

Conditions: Hoarding Disorder
Interventions: MRI with fMRI frequency; Device
Lead sponsor: Stanford University; Other
Eligibility: 18 Years to 70 Years
Enrollment: 25 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2018 – 2027
U.S. locations: 1
States / cities: Stanford, California

Conditions: Obsessive-Compulsive Disorder
Interventions: ExAblate MR-guided Focused Ultrasound Bilateral Anterior Capsulotomy; Device
Lead sponsor: Brigham and Women's Hospital; Other
Eligibility: 25 Years to 64 Years
Enrollment: 66 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2032
U.S. locations: 2
States / cities: Palo Alto, California • Boston, Massachusetts

Conditions: Obsessive-Compulsive Disorder
Interventions: Troriluzole, Placebo; Drug
Lead sponsor: Biohaven Pharmaceuticals, Inc.; Industry
Eligibility: 18 Years to 65 Years
Enrollment: 589 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2025
U.S. locations: 49
States / cities: Phoenix, Arizona • Culver City, California • La Jolla, California + 45 more

Conditions: Obsessive-Compulsive Disorder
Interventions: Psilocybin 10 mg, Psilocybin 20 mg, Psilocybin 30 mg; Drug
Lead sponsor: Francisco A Moreno; Other
Eligibility: 18 Years and older
Enrollment: 30 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2029
U.S. locations: 1
States / cities: Tucson, Arizona

Conditions: Obsessive Compulsive Disorder, Major Depressive Disorder, Epilepsy
Interventions: Deep Brain Stimulator; Device
Lead sponsor: Massachusetts General Hospital; Other
Eligibility: 18 Years to 70 Years
Enrollment: 13 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2026
U.S. locations: 2
States / cities: Boston, Massachusetts • Charlestown, Massachusetts

Conditions: Obsessive-Compulsive Disorder, Generalized Anxiety Disorder, Major Depressive Disorder
Interventions: Emotion Regulation Therapy - Attention Regulation (AR-ERT), Supportive Psychotherapy (SPT); Behavioral
Lead sponsor: Massachusetts General Hospital; Other
Eligibility: 18 Years to 60 Years
Enrollment: 65 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2025
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Obsessive-Compulsive Disorder
Interventions: Light therapy, Placebo light therapy; Behavioral
Lead sponsor: University of Colorado, Boulder; Other
Eligibility: 18 Years to 35 Years
Enrollment: 21 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2024
U.S. locations: 1
States / cities: Boulder, Colorado

Conditions: Hoarding Disorder, Hoarding, Clutter
Interventions: Facilitated group therapy with behavioral practice; 16 weeks; Behavioral
Lead sponsor: Stanford University; Other
Eligibility: 56 Years and older
Enrollment: 13 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2021
U.S. locations: 1
States / cities: Stanford, California

Conditions: Trichotillomania
Interventions: Acceptance enhanced behavior therapy (AEBT), Psychoeducation and supportive therapy (PST); Behavioral
Lead sponsor: University of Wisconsin, Milwaukee; Other
Eligibility: 18 Years to 65 Years
Enrollment: 85 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2009 – 2015
U.S. locations: 1
States / cities: Milwaukee, Wisconsin

Conditions: Obsessive Compulsive Disorder
Interventions: 5-day intensive treatment; Behavioral
Lead sponsor: Mayo Clinic; Other
Eligibility: 7 Years to 17 Years
Enrollment: 28 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2010 – 2012
U.S. locations: 3
States / cities: Tampa, Florida • Rochester, Minnesota • The Bronx, New York

Conditions: Obsessive Compulsive Disorder
Interventions: Cognitive Behavioral Therapy; Behavioral
Lead sponsor: Hartford Hospital; Other
Eligibility: 20 Years to 60 Years
Enrollment: 128 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2013 – 2019
U.S. locations: 1
States / cities: Hartford, Connecticut

Conditions: Anorexia Nervosa
Interventions: Repetitive Transcranial Magnetic Stimulation (rTMS); Device
Lead sponsor: University of California, San Francisco; Other
Eligibility: 16 Years to 75 Years
Enrollment: 20 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2026
U.S. locations: 1
States / cities: San Francisco, California

Conditions: Dystonia, Epilepsy in Children, Cerebral Palsy, Tourette Syndrome, Obsessive-Compulsive Disorder, Neurologic Disorder, Movement Disorders in Children, Movement Disorders, Deep Brain Stimulation
Interventions: Not listed
Lead sponsor: Boston Children's Hospital; Other
Eligibility: 0 Years to 18 Years
Enrollment: 100 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2029
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Obsessive-Compulsive Disorder
Interventions: Intranasal Ketamine, Intranasal Midazolam; Drug
Lead sponsor: New York State Psychiatric Institute; Other
Eligibility: 18 Years to 55 Years
Enrollment: 2 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2015
U.S. locations: 1
States / cities: New York, New York

Search by objective public record fields.

Treatment of Obsessive-Compulsive Disorder

TMS for Improving Response Inhibition in Adolescents With OCD

Enhancing Attention in Adults With Compulsive Hoarding

Patient-specific, Effective, and Rational Functional Connectivity Targeting for DBS in OCD

Family Focused Treatment of Pediatric Obsessive Compulsive Disorder

Evaluation of Family-Based Behavioral Treatments for Youth With Anxiety and Obsessive-Compulsive Disorder

Understanding How Ketamine Brings About Rapid Improvement in OCD

Study to Evaluate the Effect of AFQ056 in Obsessive Compulsive Disorder (OCD) Patients Resistant to Selective Serotonin Reuptake Inhibitor (SSRI) Therapy

An ERP-based Mobile Intervention as an Adjunctive Treatment for OCD

Imaginal Exposure for Hoarding Disorder

Neural Mechanisms of Decision Making in Hoarding Disorder

Sonication-based OCD Neurosurgical Intervention Via Capsulotomy

A Study to Evaluate the Efficacy and Safety of Adjunctive Troriluzole in Obsessive-Compulsive Disorder

Psilocybin Whole Mushroom for the Treatment of Obsessive-compulsive Disorder.

ON/OFF Stimulation and Reward Motivation in Patients With Deep Brain Stimulators

Improving Attentional and Cognitive Control in the Psychological Treatment of Intrusive Thoughts

Light Therapy for Obsessive-compulsive Disorder (OCD)

Hoarding Disorder Treatment With Virtual Reality

Testing a New Therapy for Trichotillomania

Wait-list Study of One-Week Intensive Cognitive-Behavioral Therapy for Pediatric Obsessive-Compulsive Disorder (OCD)

Neural Mechanisms of CBT Response in Hoarding Disorder

Identifying Networks Underlying Compulsivity in Anorexia Nervosa for Targeting With Neuromodulation

A Multicenter Pediatric Deep Brain Stimulation Registry

Randomized Controlled Trial of Intranasal Ketamine vs. Intranasal Midazolam in Individuals With OCD